Certain Microfluidic Systems and Components Thereof and Products Containing Same; Commission's Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Order; and Termination of the Investigation, 9478-9479 [2020-03192]

Download as PDF 9478 Federal Register / Vol. 85, No. 33 / Wednesday, February 19, 2020 / Notices support of the request to B. Sunday Eiselt, Department of Anthropology, Southern Methodist University, 3225 Daniel Avenue, Heroy Hall #450, Dallas, TX 75205, telephone (214) 768–2915, email seiselt@smu.edu, by March 20, 2020. After that date, if no additional requestors have come forward, transfer of control of the human remains to The Tribes may proceed. The Department of Anthropology, Southern Methodist University is responsible for notifying The Tribes that this notice has been published. Dated: January 21, 2020. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2020–03224 Filed 2–18–20; 8:45 am] BILLING CODE 4312–52–P DEPARTMENT OF THE INTERIOR Office of Surface Mining Reclamation and Enforcement [S1D1S SS08011000 SX064A000 201S180110; S2D2S SS08011000 SX064A000 20XS501520; OMB Control Number 1029–0116] Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Revisions; Renewal; and Transfer, Assignment, or Sale of Permit Rights Office of Surface Mining Reclamation and Enforcement, Interior. ACTION: Notice of information collection; request for comment. AGENCY: In accordance with the Paperwork Reduction Act of 1995, we, the Office of Surface Mining Reclamation and Enforcement (OSMRE) are proposing to renew an information collection. DATES: Interested persons are invited to submit comments on or before March 20, 2020. ADDRESSES: Send written comments on this information collection request (ICR) to the Office of Management and Budget’s Desk Officer for the Department of the Interior by email at OIRA_Submission@omb.eop.gov; or via facsimile to (202) 395–5806. Please provide a copy of your comments to Mark Gehlhar, Office of Surface Mining Reclamation and Enforcement, 1849 C Street NW, Room 4556–MIB, Washington, DC 20240; or by email to mgehlhar@osmre.gov. Please reference OMB Control Number 1029–0116 in the subject line of your comments. FOR FURTHER INFORMATION CONTACT: To request additional information about khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:51 Feb 18, 2020 Jkt 250001 this ICR, contact Mark Gehlhar by email at mgehlhar@osmre.gov, or by telephone at (202) 208–2716. You may also view the ICR at http://www.reginfo.gov/ public/do/PRAMain. SUPPLEMENTARY INFORMATION: In accordance with the Paperwork Reduction Act of 1995, we provide the general public and other Federal agencies with an opportunity to comment on new, proposed, revised, and continuing collections of information. This helps us assess the impact of our information collection requirements and minimize the public’s reporting burden. It also helps the public understand our information collection requirements and provide the requested data in the desired format. A Federal Register notice with a 60day public comment period soliciting comments on this collection of information was published on October 2, 2018 (83 FR 49570). No comments were received. We are again soliciting comments on the proposed ICR that is described below. We are especially interested in public comment addressing the following issues: (1) Is the collection necessary to the proper functions of the OSMRE; (2) will this information be processed and used in a timely manner; (3) is the estimate of burden accurate; (4) how might the OSMRE enhance the quality, utility, and clarity of the information to be collected; and (5) how might the OSMRE minimize the burden of this collection on the respondents, including through the use of information technology. Comments that you submit in response to this notice are a matter of public record. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Abstract: Sections 506 and 511 of Public Law 95–87 provide that persons seeking permit revisions, renewals, transfer, assignment, or sale of their permit rights for coal mining activities submit relevant information to the regulatory authority to allow the regulatory authority to determine whether the applicant meets the requirements for the action anticipated. Title of Collection: Revisions; Renewals; and Transfer, Assignment, or Sale of Permit Rights. PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 OMB Control Number: 1029–0116. Form Number: None. Type of Review: Extension of a currently approved collection. Respondents/Affected Public: Surface coal mining permit applicants and State regulatory authorities. Total Estimated Number of Annual Respondents: Varies from 185 for sale of permit rights to 2,188 for revisions from permit applicants; and 182 for sale of permit rights to 2,101 for revisions from State regulatory authorities. Total Estimated Number of Annual Responses: 3,619 responses from permit applicants and 3,511 responses from State regulatory authorities. Estimated Completion Time per Response: Varies from 2 to 70 hours per response for permit applicants; and 2 to 90 hours per response for State regulatory authorities, depending on permitting action. Total Estimated Number of Annual Burden Hours: 404,165 hours. Respondent’s Obligation: Required to obtain or retain a benefit. Frequency of Collection: One time. Total Estimated Annual Nonhour Burden Cost: $909,758. An agency may not conduct or sponsor and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The authority for this action is the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). Dated: February 12, 2020. Mark J. Gehlhar, Information Collection Clearance Officer, Division of Regulatory Support. [FR Doc. 2020–03169 Filed 2–18–20; 8:45 am] BILLING CODE 4310–05–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1100] Certain Microfluidic Systems and Components Thereof and Products Containing Same; Commission’s Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Order; and Termination of the Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined that there is a violation in the above-captioned investigation. The Commission has SUMMARY: E:\FR\FM\19FEN1.SGM 19FEN1 khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 85, No. 33 / Wednesday, February 19, 2020 / Notices further determined to issue a limited exclusion order and cease and desist order and to set a bond rate on the entered value of covered products imported during the period of Presidential review. FOR FURTHER INFORMATION CONTACT: Benjamin S. Richards, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 708–5453. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: On February 21, 2018, the Commission instituted this investigation based on a complaint filed by 10X Genomics, Inc. of Pleasanton, CA. 83 FR 7491 (Feb. 21, 2018). The complaint alleges violations of section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, or the sale within the United States after importation of certain microfluidic systems and components thereof and products containing same by reason of infringement of one or more claims of U.S. Patent Nos. 9,644,204 (‘‘the ’204 patent’’); 9,689,024 (‘‘the ’024 patent’’); 9,695,468 (‘‘the ’468 patent’’); and 9,856,530 (‘‘the ’530 patent’’). Id. The Commission’s notice of investigation named as the sole respondent Bio-Rad Laboratories, Inc. of Hercules, CA. Id. The Office of Unfair Import Investigations (‘‘OUII’’) is participating in this investigation. Id. On July 12, 2019, the administrative law judge (‘‘ALJ’’) issued the final initial determination (‘‘ID’’). The ID found a violation of section 337 by virtue of BioRad’s indirect infringement of the ’024, the ’468, and the ’530 patents. The ID found that 10X had not established a violation with respect to the ’204 patent. The ID also found that Bio-Rad failed to establish invalidity of any of the asserted claims of any patent. The ID further found that the domestic industry VerDate Sep<11>2014 17:51 Feb 18, 2020 Jkt 250001 requirement was satisfied for each of the asserted patents. Finally, the ID found that Bio-Rad had not carried its burden with respect to various additional affirmative defenses, including improper inventorship and ownership. On July 25, 2019, the ALJ issued her recommended determination on remedy and bonding. The ALJ recommended, upon a finding of violation, that the Commission issue a limited exclusion order, issue a cease and desist order, and impose a bond in the amount of twenty-five percent of the entered value of any covered products imported during the period of Presidential review. On July 29, 2019, 10X, Bio-Rad, and OUII submitted petitions seeking review of the ID. On August 6, 2019, 10X, BioRad, and OUII submitted responses to the others’ petitions. On August 26, 2019, 10X and Bio-Rad submitted comments on the public interest pursuant to Commission Rule 210.50(a)(4). On October 17, 2019, the Commission issued a notice indicating its determination to review the ID with respect to (1) all findings related to a violation based on the ’024 patent; (2) all findings related to a violation based on the ’468 patent; (3) noninfringement of the ’204 patent; (4) all findings related to a violation based on the ’530 patent; (5) Bio-Rad’s inventorship and ownership defenses; and (6) a typographical error on page 91. The same notice also requested briefing from the parties on certain of those issues, and on remedy, bonding, and the public interest. The notice also included an extension of the target date to December 19, 2019. The parties filed their initial responses to the Commission’s questions on October 31, 2019, and their replies on November 7, 2019. Upon review of the parties’ submissions, the ID, RD, and evidence of record, the Commission has determined that Bio-Rad violated section 337 by reason of infringement of asserted claims 1, 5, 17, 19, and 22 of the ’024 patent, claims 1, 6, 7, 9, and 21 of the ’468 patent, and claims 1, 4, 11, 14, 19, 26, and 28 of the ’530 patent. The Commission found no violation with respect to the ’240 patent. The Commission has further determined to issue a limited exclusion order prohibiting further importation of BioRad’s infringing microfluidic systems and a cease and desist order against BioRad. The Commission will set a bond of twenty-five percent of entered value on Bio-Rad’s infringing microfluidic systems imported during the period of Presidential review. PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 9479 The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR 210). By order of the Commission. Issued: February 12, 2020. Lisa Barton, Secretary to the Commission. [FR Doc. 2020–03192 Filed 2–18–20; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 332–574] Renewable Electricity: Potential Economic Effects of Increased Commitments in Massachusetts; Institution of Investigation and Scheduling of Hearing United States International Trade Commission. ACTION: Notice of investigation and scheduling of a public hearing. AGENCY: Following receipt on January 23, 2020, of a request from the Committee on Ways and Means (Committee) of the U.S. House of Representatives, under section 332(g) of the Tariff Act of 1930, the U.S. International Trade Commission (Commission) instituted Investigation No. 332–574, Renewable Electricity: Potential Economic Effects of Increased Commitments in Massachusetts, for the purpose of providing a report regarding the potential economic effects of increased renewable energy commitments in Massachusetts, and the role of renewable electricity imports in meeting these commitments. DATES: April 16, 2020: Deadline for filing requests to appear at the public hearing. April 23, 2020: Deadline for filing prehearing briefs and statements. May 7, 2020: Public hearing. May 15, 2020: Deadline for filing posthearing briefs and statements. July 28, 2020: Deadline for filing all other written submissions. January 25, 2021: Transmittal of Commission report to the Committee. ADDRESSES: All Commission offices, including the Commission’s hearing rooms, are located in the U.S. International Trade Commission Building, 500 E Street SW, Washington, DC. All written submissions should be addressed to the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. The public record for this investigation may SUMMARY: E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 85, Number 33 (Wednesday, February 19, 2020)]
[Notices]
[Pages 9478-9479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03192]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-1100]


Certain Microfluidic Systems and Components Thereof and Products 
Containing Same; Commission's Final Determination Finding a Violation 
of Section 337; Issuance of a Limited Exclusion Order and Cease and 
Desist Order; and Termination of the Investigation

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined that there is a violation in the above-
captioned investigation. The Commission has

[[Page 9479]]

further determined to issue a limited exclusion order and cease and 
desist order and to set a bond rate on the entered value of covered 
products imported during the period of Presidential review.

FOR FURTHER INFORMATION CONTACT: Benjamin S. Richards, Esq., Office of 
the General Counsel, U.S. International Trade Commission, 500 E Street 
SW, Washington, DC 20436, telephone (202) 708-5453. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW, Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its internet server at https://www.usitc.gov. The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: On February 21, 2018, the Commission 
instituted this investigation based on a complaint filed by 10X 
Genomics, Inc. of Pleasanton, CA. 83 FR 7491 (Feb. 21, 2018). The 
complaint alleges violations of section 337 of the Tariff Act of 1930, 
as amended, 19 U.S.C. 1337, in the importation into the United States, 
the sale for importation, or the sale within the United States after 
importation of certain microfluidic systems and components thereof and 
products containing same by reason of infringement of one or more 
claims of U.S. Patent Nos. 9,644,204 (``the '204 patent''); 9,689,024 
(``the '024 patent''); 9,695,468 (``the '468 patent''); and 9,856,530 
(``the '530 patent''). Id. The Commission's notice of investigation 
named as the sole respondent Bio-Rad Laboratories, Inc. of Hercules, 
CA. Id. The Office of Unfair Import Investigations (``OUII'') is 
participating in this investigation. Id.
    On July 12, 2019, the administrative law judge (``ALJ'') issued the 
final initial determination (``ID''). The ID found a violation of 
section 337 by virtue of Bio-Rad's indirect infringement of the '024, 
the '468, and the '530 patents. The ID found that 10X had not 
established a violation with respect to the '204 patent. The ID also 
found that Bio-Rad failed to establish invalidity of any of the 
asserted claims of any patent. The ID further found that the domestic 
industry requirement was satisfied for each of the asserted patents. 
Finally, the ID found that Bio-Rad had not carried its burden with 
respect to various additional affirmative defenses, including improper 
inventorship and ownership.
    On July 25, 2019, the ALJ issued her recommended determination on 
remedy and bonding. The ALJ recommended, upon a finding of violation, 
that the Commission issue a limited exclusion order, issue a cease and 
desist order, and impose a bond in the amount of twenty-five percent of 
the entered value of any covered products imported during the period of 
Presidential review.
    On July 29, 2019, 10X, Bio-Rad, and OUII submitted petitions 
seeking review of the ID. On August 6, 2019, 10X, Bio-Rad, and OUII 
submitted responses to the others' petitions. On August 26, 2019, 10X 
and Bio-Rad submitted comments on the public interest pursuant to 
Commission Rule 210.50(a)(4).
    On October 17, 2019, the Commission issued a notice indicating its 
determination to review the ID with respect to (1) all findings related 
to a violation based on the '024 patent; (2) all findings related to a 
violation based on the '468 patent; (3) noninfringement of the '204 
patent; (4) all findings related to a violation based on the '530 
patent; (5) Bio-Rad's inventorship and ownership defenses; and (6) a 
typographical error on page 91. The same notice also requested briefing 
from the parties on certain of those issues, and on remedy, bonding, 
and the public interest. The notice also included an extension of the 
target date to December 19, 2019.
    The parties filed their initial responses to the Commission's 
questions on October 31, 2019, and their replies on November 7, 2019.
    Upon review of the parties' submissions, the ID, RD, and evidence 
of record, the Commission has determined that Bio-Rad violated section 
337 by reason of infringement of asserted claims 1, 5, 17, 19, and 22 
of the '024 patent, claims 1, 6, 7, 9, and 21 of the '468 patent, and 
claims 1, 4, 11, 14, 19, 26, and 28 of the '530 patent. The Commission 
found no violation with respect to the '240 patent. The Commission has 
further determined to issue a limited exclusion order prohibiting 
further importation of Bio-Rad's infringing microfluidic systems and a 
cease and desist order against Bio-Rad. The Commission will set a bond 
of twenty-five percent of entered value on Bio-Rad's infringing 
microfluidic systems imported during the period of Presidential review.
    The authority for the Commission's determination is contained in 
section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and 
in part 210 of the Commission's Rules of Practice and Procedure (19 CFR 
210).

    By order of the Commission.

    Issued: February 12, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020-03192 Filed 2-18-20; 8:45 am]
 BILLING CODE 7020-02-P